Akero Therapeutics Inc (AKRO)
27.75
-2.01
(-6.75%)
USD |
NASDAQ |
Nov 15, 12:35
Akero Therapeutics Cash and Short Term Investments (Quarterly): 717.25M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 717.25M |
| June 30, 2024 | 760.19M |
| March 31, 2024 | 903.66M |
| December 31, 2023 | 550.01M |
| September 30, 2023 | 554.73M |
| June 30, 2023 | 639.44M |
| March 31, 2023 | 343.22M |
| December 31, 2022 | 351.45M |
| September 30, 2022 | 374.00M |
| June 30, 2022 | 180.72M |
| March 31, 2022 | 165.38M |
| December 31, 2021 | 188.26M |
| Date | Value |
|---|---|
| September 30, 2021 | 215.08M |
| June 30, 2021 | 230.03M |
| March 31, 2021 | 249.98M |
| December 31, 2020 | 268.39M |
| September 30, 2020 | 291.87M |
| June 30, 2020 | 102.83M |
| March 31, 2020 | 125.28M |
| December 31, 2019 | 136.40M |
| September 30, 2019 | 147.84M |
| June 30, 2019 | 162.65M |
| March 31, 2019 | 69.80M |
| December 31, 2018 | 75.98M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
102.83M
Minimum
Jun 2020
903.66M
Maximum
Mar 2024
367.41M
Average
280.13M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 998.63M |
| 89bio Inc | 423.77M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |
| iBio Inc | 14.21M |